Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of ResMed (NYSE:RMD) with a Neutral recommendation.
Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...
Barchart on MSN10d
ResMed's Quarterly Earnings Preview: What You Need to KnowBased in San Diego, California, ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and ...
Chipotle Mexican Grill owns and operates Chipotle Mexican Grill restaurants. The company’s expected earnings growth rate for ...
Zacks.com on MSN10d
ResMed Gains 37.8% in a Year: What's Driving the Stock?RMD's shares gain on the back of robust mask and device sales growth. However, the unfavorable macroeconomic scenario is ...
Piper Sandler initiated coverage of ResMed (RMD) with a Neutral rating and $252 price target While there’s a lot to like about the ResMed ...
Shares of ResMed Inc. (NYSE:RMD – Get Free Report) have earned a consensus rating of “Hold” from the thirteen brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst ...
Highlights,ResMed's stock price dips below its 200-day moving average.,The company posted strong quarterly earnings, ...
The stock's fall snapped a three-day winning streak.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback